|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115.50 GBX | -1.28% |
|
-1.28% | -13.81% |
| 06-08 | SkinBioTherapeutics restates 2025 results amid "fabricated" figures | AN |
| 05-15 | FRP Advisory expects double-digit annual revenue climb | AN |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 379M | BB | ||||||||
| 5.26B | BBB | - | - | ||||||
| 4.45B | - | AA | - | - | |||||
| 2.27B | BBB | - | |||||||
| 1.6B | - | - | - | - | - | - | - | ||
| 1.31B | AA | - | |||||||
| 1.29B | A | ||||||||
| 1.06B | - | A | - | - | - | - | - | ||
| 810M | - | - | - | - | - | - | |||
| 742M | - | - | - | - | - | - | - | ||
| 606M | BBB | - | |||||||
| 464M | CCC | ||||||||
| 455M | BB | - | - | - | |||||
| 372M | - | - | - | - | - | ||||
| 321M | - | BBB | - | - | |||||
| 267M | - | B | - | - | |||||
| 267M | - | - | |||||||
| 240M | - | - | - | - | - | - | - | ||
| 202M | - | - | - | - | - | - | - | ||
| 195M | - | - | - | - | - | - | - | ||
| Average | 1.13B | BBB | |||||||
| Weighted average by Cap. | BBB |
- Stock Market
- Stocks
- FRP Stock
- Sector FRP Advisory Group plc
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















